CORN cDNA ENCODING SOUTHERN LEAF BLIGHT RESISTANCE PROTEIN

Abstract: This invention relates to an isolated nucleic acid fragment encoding a SCLB<R> protein. The invention also relates to the construction of a chimeric gene encoding all or a portion of the SCLB<R> protein, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the SCLB<R> protein in a transformed host cell.

Description: TITLE CORN CDNA ENCODING SOUTHERN LEAF BLIGHT RESISTANCE PROTEIN This application claims the benefit of U.S. Provisional Application No. 60/064,492, filed November 5, 1997. FIELD OF THE INVENTION This invention is in the field of plant molecular biology. More specifically, this invention pertains to nucleic acid fragments encoding proteins involved in corn (Zea mays) resistance to Southern corn leaf blight disease, caused by the fungus Helminthosporium maydis. BACKGROUND OF THE INVENTION Southern or Maydis Leaf Blight is a serious disease of corn caused by Helminthosporium maydis Nisik. (Cochliobolus heterostrophus (Drechs)). While corn hybrids with normal cytoplasm are resistant to Race T of the pathogen, Race O shows no differential reaction between plants with different cytoplasms; however, sources of resistance are available (Shurtleff (1973) Compendium of Corn Diseases). Chlorotic lesion resistance to Race O was identified in an East African line of corn (Jeweus and Daniel-Kalio (1968) Plant Dis Rep. 52:134-136). The resistant plants inhibit fungal sporulation and are distinguished by the presence of small chlorotic lesions. Significantly, the resistance is recessive (Smith and Hooker (1973) Crop Science 73:330-331). It was reported that disease is controlled by two linked recessive genes. It is well established that resistance to many diseases in plants is mediated by the interaction of plant genes referred to as "i?" genes with corresponding Avr genes expressed by the pathogen (Hammond-Kosack, K. E. and Jones, J. D. G. (1997) Ann Rev. Plant Phusiol Plant Mol. Bio. 48:1-39). This interaction leads to the activation of plant responses which in turn results in increased resistance to disease. This resistance is frequently mediated by the "hypersensitive response", a localized cell death phenomenon that occurs in the areas of plant tissue invaded by the pathogen. This AvrlR interaction is race-specific; i.e., particular alleles ofthe plant R gene respond only to specific races of the pathogen which express a corresponding Avr gene (Flor, H. (1971) Ann. Rev. Phytopathol. 9:275-296). Most ofthe R genes characterized to date are dominant; i.e., resistance is exhibited by plants carrying the appropriate R allele in either an heterozygous or homozygous state. Some R genes have been isolated by map-based cloning. Many homologs of R genes have also been identified by sequence similarity. Because ofthe rapid evolution of plant resistance to disease, homology of a cDNA or genomic DNA sequence to a known R gene from a different plant species does not allow one to predict the pathogen specificity of that particular R gene. No general methods for such prediction exist today. Genes involved in resistance of plants to plant pathogens may be used to engineer disease resistance into plants normally sensitive to disease using several different approaches. Transgenic plants containing alleles of R genes demonstrate resistance to corresponding races ofthe pathogen (Wang, G.-L. et al. (1996) Mol. Plant-Microbe Interact. 9 9 :850-855). The resistance genes may also be engineered to respond to non-native signals derived from the pathogen. In addition, pathogen-derived Avr genes may be expressed in a controlled manner in plants to strengthen the response to a pathogen. Genes further downstream from the R genes in the signal transduction pathways that transmit signals to the disease response effector genes may be engineered to directly respond to pathogen infection, thereby shortening the response pathway. The process ofthe hypersensitive response to a pathogen, and the signaling networks involved, are poorly understood. In no case have all ofthe genes involved in transmitting the signal from the pathogen to the site ofthe initiation ofthe hypersensitive response been identified. In a few cases, the functioning of a disease resistance mechanism different from the AvrlR interaction described above results in a recessive, rather than dominant pattern of resistance. One such example is the Mlo gene of barley, which conveys resistance to Erysiphe graminisf. sp. hordei. The barley gene has been recently isolated by a positional cloning approach (Bueschges, R. et al. (1997) Cell 88:695-105). The dominant (sensitive) allele (Mlo) is thought to encode a protein involved in regulation of leaf cell death and in the onset of pathogen defense. The partial or complete inactivation of Mlo results in the priming ofthe disease-resistance response even in the absence ofthe pathogen, and leads to increased resistance to E. graminis. The available scientific data concerning Mlo-mediated disease resistance in barley points towards another approach to controlling disease: priming the pathogen response pathway by diminishing the effectiveness of negative regulation of the hypersensitive response. Appropriately engineered plants may show increased pathogen resistance at the expense of expressing some pathogen response-related genes even in the absence of pathogen. Sense or antisense inhibition or targeted gene disruption of Mlo and Mlo-related genes may have such an effect. Resistance to other pathogens may also be increased using this approach. Mlo-related cDNA clones and DNA segments of genomic DNA, and their homologs and derivatives, may also be used as molecular probes to track inheritance of corresponding loci in genetic crosses, and thus facilitate the plant breeding process. Moreover, these DNA sequences may also be used as probes to isolate, identify and genetically map Mlo and other closely related disease resistance genes. SUMMARY OF THE INVENTION The instant invention relates to isolated nucleic acid fragments encoding a corn homolog of the barley Mlo protein. Specifically, the instant invention relates to isolated nucleic acid fragments encoding plant proteins involved in the regulation of plant cell death response in corn which, surprisingly, is associated with resistance of corn to Southern corn leaf blight disease caused by the fungus Helminthosporium maydis. In addition, this invention relates to nucleic acid fragments that are complementary to nucleic acid fragments encoding a corn homolog ofthe barley Mlo protein. The corn homolog ofthe barley Mlo gene and corresponding protein will hereinafter be referred to as the putative Southern corn leaf blight Resistance or SCLB R gene or protein, respectively. An additional embodiment ofthe instant invention pertains to a polypeptide encoding all or a substantial portion of a SCLB R protein. In another embodiment, the instant invention relates to a chimeric gene that comprises a nucleic acid fragment encoding the SCLB R protein or to a chimeric gene that comprises a nucleic acid fragment that is complementary to the nucleic acid fragment encoding the SCLB R protein, operably linked to suitable regulatory sequences, wherein expression ofthe chimeric gene results in production of levels of a SCLB R protein in transformed host cells that are altered (i.e., increased or decreased) from the levels produced in untransformed host cells. In a further embodiment, the instant invention concerns a transformed host cell comprising in its genome a chimeric gene encoding a SCLB R , operably linked to suitable regulatory sequences. Expression ofthe chimeric gene results in production of altered levels ofthe encoded protein in the transformed host cell. The transformed host cell can be of eukaryotic or prokaryotic origin, and include cells derived from higher plants and microorganisms. The invention also includes transformed plants that arise from transformed host cells of higher plants, and seeds derived from such transformed plants. An additional embodiment ofthe instant invention concerns a method of altering the level of expression of a SCLB R protein in a transformed host cell comprising: a) transforming a host cell with a chimeric gene comprising a nucleic acid fragment encoding a SCLB R protein; and b) growing the transformed host cell under conditions that are suitable for expression ofthe chimeric gene wherein expression ofthe chimeric gene results in production of altered levels of SCLB R protein in the transformed host cell. An addition embodiment ofthe instant invention concerns a method for obtaining a nucleic acid fragment encoding all or a substantial portion of an amino acid sequence encoding a SCLB R protein. A further embodiment ofthe instant invention concerns a method for using the instant nucleic acid fragments and their homologs and derivatives as molecular probes to monitor inheritance of corresponding loci in genetic crosses, and thus to facilitate and accelerate plant breeding. Additionally, the instant nucleic acid fragments may be used as probes to isolate, identify and genetically map SCLB R and other closely related disease resistance genes. BRIEF DESCRIPTION OF THE DRAWINGS AND SEQUENCE DESCRIPTIONS The invention can be more fully understood from the following detailed description and the accompanying drawings and Sequence Listing which form a part of this application. Figure 1 is a genetic map of chromosome 6 of corn, including the position of cDNA clone ctal.pk0005.cl. The map was constructed using Mapmaker 3.0 for the Macintosh (Lander, E. S. et al. (1987) Genomics 7:174-181) and mapping data from Burr et al. (Burr et al. (1988) Genetics 775:519-526). Figure 2 is an alignment of nucleotides 781 to 1390 ofthe contig assembled with the nucleotide sequence of cDNA insert in clone ctal.pk0005.cl and the 5'RACE product obtained using PCR primer P3 (SEQ ID NO:9) with the sequences ofthe 703 bp (SEQ ID NO: 17) product obtained by PCR amplification of corn genomic DNA using primers PI and P2. The extent ofthe intron sequences is indicated with an arrow. Intron sequences are shown in lowercase. The gt/ag invariant intron boundary sequences are bold and underlined. Figure 3 is an alignment of nucleotides 60 to 520 from the sequence of cDNA mlo3b3 (SEQ ID NO:l 1) with the sequence ofthe 765 bp (SEQ ID NO:18) product obtained by PCR amplification of corn genomic DNA using primers PI and P2. The extent ofthe intron sequences is indicated with an arrow. Intron sequences are shown in lowercase. The gt/ag invariant intron boundary sequences are bold and underlined. The following sequence descriptions and Sequence Listing attached hereto comply with the rules governing nucleotide and/or amino acid sequence disclosures in patent applications as set forth in 37 C.F.R. §1.821-1.825. SEQ ID NO:l is the nucleotide sequence comprising the entire cDNA insert in clone cc3.pk0007.g3 encoding an almost full-length SCLB R protein. SEQ ID NO:2 is the deduced amino acid sequence of an almost full-length SCLB R protein derived from the nucleotide sequence of SEQ ID NO:l. SEQ ID NO: 3 is the nucleotide sequence comprising a portion ofthe cDNA insert in clone crln.pk0154.a3 encoding the C-terminal half of a SCLB R protein. SEQ ID NO:4 is the deduced amino acid sequence ofthe C-terminal half of a SCLB R protein derived from the nucleotide sequence of SEQ ID NO:3. SEQ ID NO: 5 is the nucleotide sequence comprising a portion ofthe cDNA insert in clone csl.pk0071.e3 encoding the C-terminus of a SCLB R protein. SEQ ID NO:6 is the deduced amino acid sequence ofthe C-terminus of a SCLB R protein derived from the nucleotide sequence of SEQ ID NO:5. SEQ ID NO:7is the nucleotide sequence comprising the entire cDNA insert in clone ccol.pk0052.bl0 encoding a full-length SCLB R protein. SEQ ID NO:8is the deduced amino acid sequence of a full-length SCLB R protein derived from the nucleotide sequence of SEQ ID NO:7. SEQ ID NO:9 is the nucleotide sequence comprising a contig assembled from the entire cDNA insert in clone ctal.pk0005.cl and the 5' RACE PCR product obtained using PCR primer P3 encoding a full-length SCLB R protein. SEQ ID NO: 10 is the deduced amino acid sequence of a full-length SCLB R protein derived from the nucleotide sequence of SEQ ID NO:9. SEQ ID NO:l 1 is the nucleotide sequence comprising mlo3b3, the 3' RACE PCR product obtained using clone ctal.pk0005.cl and PCR primer PI, encoding a fragment of a SCLB R protein. SEQ ID NO: 12 is the deduced amino acid sequence of a fragment of a SCLB R protein derived from the nucleotide sequence of SEQ ID NO: 11. SEQ ID NO: 13 is the nucleotide sequence comprising a portion ofthe cDNA insert in clone cen3n.pk0062.b7 encoding a fragment of a SCLB R protein. SEQ ID NO: 14 is the deduced amino acid sequence of a fragment of a SCLB R protein derived from the nucleotide sequence of SEQ ID NO: 13. SEQ ID NO : 15 is the nucleotide sequence of PCR primer P 1. SEQ ID NO: 16 is the nucleotide sequence of PCR primer P2. SEQ ID NO: 17 is the nucleotide sequence ofthe 703 bp PCR product obtained by amplification of corn genomic DNA using PCR primers PI and P2 SEQ ID NO: 18. is the nucleotide sequence ofthe 765 bp PCR product obtained by amplification of corn genomic DNA using PCR primers PI and P2. SEQ ID NO: 19 is the nucleotide sequence of PCR primer P3. SEQ ID NO:20 is the nucleotide sequence of PCR primer P4. The Sequence Listing contains the one letter code for nucleotide sequence characters and the three letter codes for amino acids as defined in conformity with the IUPAC-IUBMB standards described in Nucleic Acids Research 73:3021-3030 (1985) and in the Biochemical Journal 219 (No. 2):345-373 (1984) which are herein incorporated by reference. The symbols and format used for nucleotide and amino acid sequence data comply with the rules set forth in 37 C.F.R. §1.822. DETAILED DESCRIPTION OF THE INVENTION In the context of this disclosure, a number of terms shall be utilized. As used herein, an "isolated nucleic acid fragment" is a polymer of RNA or DNA that is single- or double- stranded, optionally containing synthetic, non-natural or altered nucleotide bases. An isolated nucleic acid fragment in the form of a polymer of DNA may be comprised of one or more segments of cDNA, genomic DNA or synthetic DNA. As used herein, "contig" refers to an assemblage of overlapping nucleic acid sequences to form one contiguous nucleotide sequence. For example, several DNA sequences can be compared and aligned to identify common or overlapping regions. The individual sequences can then be assembled into a single contiguous nucleotide sequence. As used herein, "substantially similar" refers to nucleic acid fragments wherein changes in one or more nucleotide bases results in substitution of one or more amino acids, but do not affect the functional properties ofthe protein encoded by the DNA sequence. "Substantially similar" also refers to nucleic acid fragments wherein changes in one or more nucleotide bases does not affect the ability ofthe nucleic acid fragment to mediate alteration of gene expression by antisense or co-suppression technology. "Substantially similar" also refers to modifications ofthe nucleic acid fragments ofthe instant invention such as deletion or insertion of one or more nucleotides that do not substantially affect the functional properties ofthe resulting transcript vis-a-vis the ability to mediate alteration of gene expression by antisense or co-suppression technology or alteration ofthe functional properties ofthe resulting protein molecule. It is therefore understood that the invention encompasses more than the specific exemplary sequences. For example, it is well known in the art that antisense suppression and co-suppression of gene expression may be accomplished using nucleic acid fragments representing less than the entire coding region of a gene, and by nucleic acid fragments that do not share 100% sequence identity with the gene to be suppressed. Moreover, alterations in a gene which result in the production of a chemically equivalent amino acid at a given site, but do not effect the functional properties ofthe encoded protein, are well known in the art. Thus, a codon for the amino acid alanine, a hydrophobic amino acid, may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine. Similarly, changes which result in substitution of one negatively charged residue for another, such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine, can also be expected to produce a functionally equivalent product. Nucleotide changes which result in alteration of the N-terminal and C-terminal portions ofthe protein molecule would also not be expected to alter the activity ofthe protein. Each ofthe proposed modifications is well within the routine skill in the art, as is determination of retention of biological activity ofthe encoded products. Moreover, the skilled artisan recognizes that substantially similar nucleic acid sequences encompassed by this invention are also defined by their ability to hybridize, under stringent conditions (0.1X SSC, 0.1% SDS, 65°C), with the sequences exemplified herein. Preferred substantially similar nucleic acid fragments of the instant invention are those nucleic acid fragments whose DNA sequences are 80% identical to the coding sequence of the nucleic acid fragments reported herein. More preferred nucleic acid fragments are 90% identical to the coding sequence ofthe nucleic acid fragments reported herein. Most preferred are nucleic acid fragments that are 95% identical to the coding sequence ofthe nucleic acid fragments reported herein. A "substantial portion" of an amino acid or nucleotide sequence comprises enough of the amino acid sequence of a polypeptide or the nucleotide sequence of a gene to afford putative identification of that polypeptide or gene, either by manual evaluation ofthe sequence by one skilled in the art, or by computer-automated sequence comparison and identification using algorithms such as BLAST (Basic Local Alignment Search Tool; Altschul, S. F., et al., (1993) J. Mol. Biol. 275:403-410; see also www.ncbi.nlm.nih.gov/BLAST/). In general, a sequence often or more contiguous amino acids or thirty or more nucleotides is necessary in order to putatively identify a polypeptide or nucleic acid sequence as homologous to a known protein or gene. Moreover, with respect to nucleotide sequences, gene specific oligonucleotide probes comprising 20-30 contiguous nucleotides may be used in sequence-dependent methods of gene identification (e.g., Southern hybridization) and isolation (e.g., in situ hybridization of bacterial colonies or bacteriophage plaques). In addition, short oligonucleotides of 12-15 bases may be used as amplification primers in PCR in order to obtain a particular nucleic acid fragment comprising the primers. Accordingly, a "substantial portion" of a nucleotide sequence comprises enough ofthe sequence to afford specific identification and/or isolation of a nucleic acid fragment comprising the sequence. The instant specification teaches partial or complete amino acid and nucleotide sequences encoding one or more particular plant proteins. The skilled artisan, having the benefit ofthe sequences as reported herein, may now use all or a substantial portion ofthe disclosed sequences for purposes known to those skilled in this art. Accordingly, the instant invention comprises the complete sequences as reported in the accompanying Sequence Listing, as well as substantial portions of those sequences as defined above. "Codon degeneracy" refers to divergence in the genetic code permitting variation of the nucleotide sequence without effecting the amino acid sequence of an encoded polypeptide. Accordingly, the instant invention relates to any nucleic acid fragment that encodes all or a substantial portion ofthe amino acid sequence encoding the SCLB R protein as set forth in SEQ ID NOs: 2, 4, 6, 8, 10, 12 and 14. The skilled artisan is well aware ofthe "codon-bias" exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid. Therefore, when synthesizing a gene for improved expression in a host cell, it is desirable to design the gene such that its frequency of codon usage approaches the frequency of preferred codon usage ofthe host cell. "Synthetic genes" can be assembled from oligonucleotide building blocks that are chemically synthesized using procedures known to those skilled in the art. These building blocks are ligated and annealed to form gene segments which are then enzymatically assembled to construct the entire gene. "Chemically synthesized", as related to a sequence of DNA, means that the component nucleotides were assembled in vitro. Manual chemical synthesis of DNA may be accomplished using well established procedures, or automated chemical synthesis can be performed using one of a number of commercially available machines. Accordingly, the genes can be tailored for optimal gene expression based on optimization of nucleotide sequence to reflect the codon bias ofthe host cell. The skilled artisan appreciates the likelihood of successful gene expression if codon usage is biased towards those codons favored by the host. Determination of preferred codons can be based on a survey of genes derived from the host cell where sequence information is available. "Gene" refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5' non-coding sequences) and following (3' non-coding sequences) the coding sequence. "Native gene" refers to a gene as found in nature with its own regulatory sequences. "Chimeric gene" refers any gene that is not a native gene, comprising regulatory and coding sequences that are not found together in nature. Accordingly, a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different than that found in nature. "Endogenous gene" refers to a native gene in its natural location in the genome of an organism. A "foreign" gene refers to a gene not normally found in the host organism, but that is introduced into the host organism by gene transfer. Foreign genes can comprise native genes inserted into a non-native organism, or chimeric genes. A "transgene" is a gene that has been introduced into the genome by a transformation procedure. "Coding sequence" refers to a DNA sequence that codes for a specific amino acid sequence. "Regulatory sequences" refer to nucleotide sequences located upstream (5' non- coding sequences), within, or downstream (3' non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation ofthe associated coding sequence. Regulatory sequences may include promoters, translation leader sequences, introns, and polyadenylation recognition sequences. "Promoter" refers to a DNA sequence capable of controlling the expression of a coding sequence or functional RNA. In general, a coding sequence is located 3' to a promoter sequence. The promoter sequence consists of proximal and more distal upstream elements, the latter elements often referred to as enhancers. Accordingly, an "enhancer" is a DNA sequence which can stimulate promoter activity and may be an innate element ofthe promoter or a heterologous element inserted to enhance the level or tissue-specificity of a promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic DNA segments. It is understood by those skilled in the art that different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. Promoters which cause a gene to be expressed in most cell types at most times are commonly referred to as "constitutive promoters". New promoters of various types useful in plant cells are constantly being discovered; numerous examples may be found in the compilation by Okamuro and Goldberg, (1989) Biochemistry of Plants 75:1-82. It is further recognized that since in most cases the exact boundaries of regulatory sequences have not been completely defined, DNA fragments of different lengths may have identical promoter activity. The "translation leader sequence" refers to a DNA sequence located between the promoter sequence of a gene and the coding sequence. The translation leader sequence is present in the fully processed mRNA upstream ofthe translation start sequence. The translation leader sequence may affect processing ofthe primary transcript to mRNA, mRNA stability or translation efficiency. Examples of translation leader sequences have been described (Turner, R. and Foster, G.D. (1995) Molecular Biotechnology 3:225). The "3' non-coding sequences" refer to DNA sequences located downstream of a coding sequence and include polyadenylation recognition sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression. The polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3' end ofthe mRNA precursor. The use of different 3' non-coding sequences is exemplified by Ingelbrecht et al., (1989) Plant Cell 7:671-680. "RNA transcript" refers to the product resulting from RNA polymerase-catalyzed transcription of a DNA sequence. When the RNA transcript is a perfect complementary copy ofthe DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from posttranscriptional processing ofthe primary transcript and is referred to as the mature RNA. "Messenger RNA (mRNA)" refers to the RNA that is without introns and that can be translated into protein by the cell. "cDNA" refers to a double-stranded DNA that is complementary to and derived from mRNA. "Sense" RNA refers to RNA transcript that includes the mRNA and so can be translated into protein by the cell. "Antisense RNA" refers to a RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene (U.S. Pat. No. 5,107,065, incorporated herein by reference). The complementarity of an antisense RNA may be with any part ofthe specific gene transcript, i.e., at the 5' non-coding sequence, 3' non-coding sequence, introns, or the coding sequence. "Functional RNA" refers to antisense RNA, ribozyme RNA, or other RNA that may not be translated but yet has an effect on cellular processes. The term "operably linked" refers to the association of nucleic acid sequences on a single nucleic acid fragment so that the function of one is affected by the other. For example, a promoter is operably linked with a coding sequence when it is capable of affecting the expression of that coding sequence (i.e., that the coding sequence is under the transcriptional control ofthe promoter). Coding sequences can be operably linked to regulatory sequences in sense or antisense orientation. The term "expression", as used herein, refers to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from the nucleic acid fragment of the invention. Expression may also refer to translation of mRNA into a polypeptide. "Antisense inhibition" refers to the production of antisense RNA transcripts capable of suppressing the expression ofthe target protein. "Overexpression" refers to the production of a gene product in transgenic organisms that exceeds levels of production in normal or non-transformed organisms. "Co-suppression" refers to the production of sense RNA transcripts capable of suppressing the expression of identical or substantially similar foreign or endogenous genes (U.S. Pat. No. 5,231,020, incorporated herein by reference). "Altered levels" refers to the production of gene product(s) in transgenic organisms in amounts or proportions that differ from that of normal or non-transformed organisms. "Mature" protein refers to a post-translationally processed polypeptide; i.e., one from which any pre- or propeptides present in the primary translation product have been removed. "Precursor" protein refers to the primary product of translation of mRNA; i.e., with pre- and propeptides still present. Pre- and propeptides may be but are not limited to intracellular localization signals. A "chloroplast transit peptide" is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the chloroplast or other plastid types present in the cell in which the protein is made. "Chloroplast transit sequence" refers to a nucleotide sequence that encodes a chloroplast transit peptide. A "signal peptide" is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the secretory system (Chrispeels, J.J., (1991) Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53). If the protein is to be directed to a vacuole, a vacuolar targeting signal (supra) can further be added, or if to the endoplasmic reticulum, an endoplasmic reticulum retention signal {supra) may be added. If the protein is to be directed to the nucleus, any signal peptide present should be removed and instead a nuclear localization signal included (Raikhel (1992) Plant Phys.100:1621 A632). "Transformation" refers to the transfer of a nucleic acid fragment into the genome of a host organism, resulting in genetically stable inheritance. Host organisms containing the transformed nucleic acid fragments are referred to as "transgenic" organisms. Examples of methods of plant transformation include Agrobacterium-mediated transformation (De Blaere et al. (1987) Meth. Enzymol. 143:211) and particle-accelerated or "gene gun" transformation technology (Klein et al. (1987) Nature (London) 327:70-73; U.S. Pat. No. 4,945,050, incorporated herein by reference). Standard recombinant DNA and molecular cloning techniques used herein are well known in the art and are described more fully in Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989 (hereinafter "Maniatis"). Nucleic acid fragments encoding at least a portion of several corn homologs ofthe barley Mlo protein have been isolated and identified by comparison of random plant cDNA sequences to public databases containing nucleotide and protein sequences using the BLAST algorithms well known to those skilled in the art. These nucleic acid fragments encode plant proteins involved in the regulation of plant cell death response in corn which, surprisingly, is associated with resistance of corn to southern corn leaf blight disease caused by the fungus Helminthosporium maydis. Table 1 lists the designation ofthe cDNA clones that comprise the nucleic acid fragments encoding SCLB R proteins. TABLE 1 Corn Homologs of Barley Mlo Protein Enzyme Clone Plant SCLB R protein cc3.pk0007.g3 corn ccol.pk0052.bl0 corn cen3n.pk0062.b7 corn crln.ρk0154.a3 corn csl.pk0071.e3 corn ctal.pk0005.cl corn mlo3b3 corn The homology with the barley Mlo protein indicated that these cDNAs corresponded to genes involved in disease resistance, but did not provide information as to the possible disease specificity in corn; Erysiphe graminis, the causative agent of powdery mildew in barley, is not a pathogen of corn. Ultimately, disease specificity information was provided by genetic mapping experiments. PCR amplification of maize genomic DNA using two primers, PI and P2, designed using the nucleic acid sequence of cDNA clone etal .pk0005.cl , resulted in the amplification of two DNA segments, both homologous to ctal.pk0005.cl, but differing in the numbers of introns (see Example 4). Genetic mapping experiments (see Example 5) placed one ofthe two genomic segments on chromosome 6, in Bin 6.01, between markers BNL7.28 and UMC59. Three disease resistance loci map to the same bin on chromosome 6: maize dwarf mosaic virus (MDMV), wheat streak mosaic virus (WSMV) and Southern corn leaf blight (SCLB). Ofthe three disease resistance loci, the SCLB locus is unique in that it is the only known recessive disease resistance locus in corn. Therefore, it is highly likely that the Mlo homolog represented by the 765 bp amplification product containing three introns corresponds to the Southern corn leaf blight resistance (SCLB R ) gene. The second genomic sequence, which contains two introns, is likely to be a second, linked SCLB R gene. The existence of two linked genes has been reported by Craig and Fajeminsin (Craig, J. and Fagemisin, J.M (1969) Plant Dis. Rep. 53:742-743). The nucleic acid fragments ofthe instant invention may be used to isolate cDNAs and genes encoding homologous SCLB R proteins from the same or other plant species. Isolation of homologous genes using sequence-dependent protocols is well known in the art. Examples of sequence-dependent protocols include, but are not limited to, methods of nucleic acid hybridization, and methods of DNA and RNA amplification as exemplified by various uses of nucleic acid amplification technologies (e.g., polymerase chain reaction, ligase chain reaction). For example, genes encoding other SCLB R proteins, either as cDNAs or genomic DNAs, could be isolated directly by using all or a portion ofthe instant nucleic acid fragments as DNA hybridization probes to screen libraries from any desired plant employing methodology well known to those skilled in the art. Specific oligonucleotide probes based upon the instant nucleic acid sequences can be designed and synthesized by methods known in the art (Maniatis). Moreover, the entire sequences can be used directly to synthesize DNA probes by methods known to the skilled artisan such as random primer DNA labeling, nick translation, or end-labeling techniques, or RNA probes using available in vitro transcription systems. In addition, specific primers can be designed and used to amplify a part or all of the instant sequences. The resulting amplification products can be labeled directly during amplification reactions or labeled after amplification reactions, and used as probes to isolate full length cDNA or genomic fragments under conditions of appropriate stringency. In addition, two short segments ofthe instant nucleic acid fragments may be used in polymerase chain reaction protocols to amplify longer nucleic acid fragments encoding homologous genes from DNA or RNA. The polymerase chain reaction may also be performed on a library of cloned nucleic acid fragments wherein the sequence of one primer is derived from the instant nucleic acid fragments, and the sequence ofthe other primer takes advantage ofthe presence ofthe polyadenylic acid tracts to the 3' end ofthe mRNA precursor encoding plant genes. Alternatively, the second primer sequence may be based upon sequences derived from the cloning vector. For example, the skilled artisan can follow the RACE protocol (Frohman et al., (1988) Proc. Natl. Acad. Sci. USA £5:8998) to generate cDNAs by using PCR to amplify copies ofthe region between a single point in the transcript and the 3' or 5' end. Primers oriented in the 3' and 5' directions can be designed from the instant sequences. Using commercially available 3' RACE or 5' RACE systems (BRL), specific 3' or 5' cDNA fragments can be isolated (Ohara et al., (1989) Proc. Natl. Acad. Sci USA 86:5613; Loh et al., (1989) Science 243:211). Products generated by the 3' and 5' RACE procedures can be combined to generate full-length cDNAs (Frohman, M.A. and Martin, G.R., (1989) Techniques 7:165). Availability ofthe instant nucleotide and deduced amino acid sequences facilitates immunological screening of cDNA expression libraries. Synthetic peptides representing portions ofthe instant amino acid sequences may be synthesized. These peptides can be used to immunize animals to produce polyclonal or monoclonal antibodies with specificity for peptides or proteins comprising the amino acid sequences. These antibodies can be then be used to screen cDNA expression libraries to isolate full-length cDNA clones of interest (Lerner, R.A. (1984) Adv. Immunol. 36:\ ; Maniatis). The nucleic acid fragments ofthe instant invention may be used to create transgenic plants in which the disclosed SCLB R proteins are present at higher or lower levels than normal or in cell types or developmental stages in which they are not normally found. This would have the effect of altering the level of SCLB R in those cells, and thus changing the ability of corn to resist certain diseases. Overexpression ofthe SCLB R proteins ofthe instant invention may be accomplished by first constructing a chimeric gene in which the coding region is operably linked to a promoter capable of directing expression of a gene in the desired tissues at the desired stage of development. For reasons of convenience, the chimeric gene may comprise promoter sequences and translation leader sequences derived from the same genes. 3' Non-coding sequences encoding transcription termination signals may also be provided. The instant chimeric gene may also comprise one or more introns in order to facilitate gene expression. Plasmid vectors comprising the instant chimeric gene can then constructed. The choice of plasmid vector is dependent upon the method that will be used to transform host plants. The skilled artisan is well aware ofthe genetic elements that must be present on the plasmid vector in order to successfully transform, select and propagate host cells containing the chimeric gene. The skilled artisan will also recognize that different independent transformation events will result in different levels and patterns of expression (Jones et al., (1985) EMBO J 4:2411-2418; De Almeida et al, (1989) Mol. Gen. Genetics 275:78-86), and thus that multiple events must be screened in order to obtain lines displaying the desired expression level and pattern. Such screening may be accomplished by Southern analysis of DNA, Northern analysis of mRNA expression, Western analysis of protein expression, or phenotypic analysis. For some applications it may be useful to direct the instant SCLB R gene product to different cellular compartments, or to facilitate its secretion from the cell. It is thus envisioned that the chimeric gene described above may be further supplemented by altering the coding sequence to encode SCLB R proteins with appropriate intracellular targeting sequences such as transit sequences (Keegstra, K. (1989) Cell 56:247-253), signal sequences or sequences encoding endoplasmic reticulum localization (Chrispeels, J.J., (1991) Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53), or nuclear localization signals (Raikhel, N. (1992) Plant Phys.100:1621-1632) added and/or with targeting sequences that are already present removed. While the references cited give examples of each of these, the list is not exhaustive and more targeting signals of utility may be discovered in the future. It may also be desirable to reduce or eliminate expression of genes encoding SCLB R proteins in plants for some applications. In order to accomplish this, a chimeric gene designed for co-suppression ofthe instant SCLB R protein can be constructed by linking a gene or gene fragment encoding an SCLB R protein to plant promoter sequences. Alternatively, a chimeric gene designed to express antisense RNA for all or part ofthe instant nucleic acid fragment can be constructed by linking the gene or gene fragment in reverse orientation to plant promoter sequences. Either the co-suppression or antisense chimeric genes could be introduced into plants via transformation wherein expression ofthe corresponding endogenous genes are reduced or eliminated. For example, the instant nucleic acid fragments may be combined in sense or antisense orientation with a suitable plant expression vector comprising a strong plant promoter sequence and plant terminator sequences. The recombinant vector may then be introduced into plants by transformation using techniques well known to those skilled in this art. Some ofthe transgenic plants recovered from the transformation process will exhibit diminished expression ofthe gene corresponding to the instant nucleic acid fragments. These plants may be identified by Northern blot analysis. These individuals may then be tested for disease resistance, and resistant individuals recovered for future use as a source of genetically controlled resistance in plant breeding schemes. Longer cDNA clones, especially ctal.pk0005.cl, cc3.pk0007.g3 and ccol .pk0052.bl0 are preferred. cDNA clones csl.pk0071.e3, crln.pk0154.a3, mlo3b3 and cen3n.pk0062.b7 may also be used in a similar way to inhibit expression of their corresponding genes. The instant SCLB R protein (or portions thereof) may be produced in heterologous host cells, particularly in the cells of microbial hosts, and can be used to prepare antibodies to the these proteins by methods well known to those skilled in the art. The antibodies are useful for detecting SCLB R protein in situ in cells or in vitro in cell extracts. Preferred heterologous host cells for production ofthe instant SCLB R protein are microbial hosts. Microbial expression systems and expression vectors containing regulatory sequences that direct high level expression of foreign proteins are well known to those skilled in the art. Any of these could be used to construct a chimeric gene for production ofthe instant SCLB R protein. This chimeric gene could then be introduced into appropriate microorganisms via transformation to provide high level expression ofthe encoded SCLB R protein. An example of a vector for high level expression ofthe SCLB R protein in a bacterial host is provided (Example 8). All or a substantial portion ofthe nucleic acid fragments ofthe instant invention may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. For example, the instant nucleic acid fragments may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Maniatis) of restriction-digested plant genomic DNA may be probed with the nucleic acid fragments ofthe instant invention. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et at., (1987) Genomics 7:174-181) in order to construct a genetic map. In addition, the nucleic acid fragments ofthe instant invention may be used to probe Southern blots containing restriction endonuclease-treated genomic DN As of a set of individuals representing parent and progeny of a defined genetic cross. Segregation ofthe DNA polymorphisms is noted and used to calculate the position ofthe instant nucleic acid sequence in the genetic map previously obtained using this population (Botstein, D. et al., (1980) Am. J. Hum. Genet. 32:314-331). The production and use of plant gene-derived probes for use in genetic mapping is described in R. Bernatzky, R. and Tanksley, S. D. (1986) Plant Mol Biol. Reporter 4(l):31-4l. Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art. Nucleic acid probes derived from the instant nucleic acid sequences may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel, J. D., et al., In: Nonmammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein). In another embodiment, nucleic acid probes derived from the instant nucleic acid sequences may be used in direct fluorescence in situ hybridization (FISH) mapping (Trask, B. J. (1991) Trends Genet. 7:149-154). Although current methods of FISH mapping favor use of large clones (several to several hundred KB; see Laan, M. et al. (1995) Genome Research 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes. A variety of nucleic acid amplification-based methods of genetic and physical mapping may be carried out using the instant nucleic acid sequences. Examples include allele-specific amplification (Kazazian, H. H. (1989) J. Lab. Clin. Med. 114(2) :95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield, V. C. et al. (1993) Genomics 76:325-332), allele-specific ligation (Landegren, U. et al. (1988) Science 247:1077-1080), nucleotide extension reactions (Sokolov, B. P. (1990) Nucleic Acid Res. 75:3671), Radiation Hybrid Mapping (Walter, M. A. et al. (1997) Nature Genetics 7:22-28) and Happy Mapping (Dear, P. H. and Cook, P. R. (1989) Nucleic Acid Res. 77:6795-6807). For these methods, the sequence of a nucleic acid fragment is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods. For example, genetic diagnostics ofthe southern corn leaf blight (SCLB), maize dwarf mosaic virus (MDMV), wheat streak mosaic virus (WSMV) loci, and of other loci corresponding or tightly linked to etal .pk0005.cl and related cDNAs may be performed. Knowledge and availability ofthe nucleotide sequences corresponding to the corn Mlo homolog embodied by cDNA clone ctal.pk0005.cl allows one skilled in the art to use one of many generally known techniques, like restriction fragment length polymorphism, allele specific PCR, single strand conformational polymorphism, allele-specific ligation, Cleaved Amplified Polymorphic Fragments (CAPS) and other similar methods discussed above and known to those skilled in the art, to follow the inheritance of a particular allele in genetic crosses during the process of plant breeding. Through this process, the plant carrying the alleles conferring disease resistance may be always recovered reliably. For example, the 765 bp PCR fragment, which is produced only from the CM37 genotype and not from the T232 genotype using primers designed from the nucleotide sequence of cDNA clone etal .pk0005.c 1 , is therefore polymorphic between these two genotypes and could be used to follow inheritance ofthe allele corresponding to the 765 bp PCR fragment in crosses of CM37 and T232, and in any crosses with a genotype which does not produce the 765 bp fragment in the above described PCR process. Loss of function mutant phenotypes may be identified for the instant cDNA clones either by targeted gene disruption protocols or by identifying specific mutants for these genes contained in a maize population carrying mutations in all possible genes (Ballinger and Benzer, (1989) Proc. Natl Acad. Sci USA 56:9402; Koes et al., (1995) Proc. Natl. Acad. Sci USA 92:8149; Bensen et al., (1995) Plant Cell 7:15). The latter approach may be accomplished in two ways. First, short segments ofthe instant nucleic acid fragments may be used in polymerase chain reaction protocols in conjunction with a mutation tag sequence primer on DNAs prepared from a population of plants in which Mutator transposons or some other mutation-causing DNA element has been introduced (see Bensen, supra). The amplification of a specific DNA fragment with these primers indicates the insertion ofthe mutation tag element in or near the plant SCLB R gene. Alternatively, the instant nucleic acid fragment may be used as a hybridization probe against PCR amplification products generated from the mutation population using the mutation tag sequence primer in conjunction with an arbitrary genomic site primer, such as that for a restriction enzyme site- anchored synthetic adaptor. With either method, a plant containing a mutation in the endogenous SCLB R gene can be identified and obtained. This mutant plant can then be used to determine or confirm the natural function ofthe SCLB R gene product. EXAMPLES The present invention is further defined in the following Examples, in which all parts and percentages are by weight and degrees are Celsius, unless otherwise stated. It should be understood that these Examples, while indicating preferred embodiments ofthe invention, are given by way of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions. EXAMPLE 1 Composition of cDNA Libraries; Isolation and Sequencing of cDNA Clones cDNA libraries representing mRNAs from various corn tissues were prepared. The characteristics ofthe libraries are described below. TABLE 2 cDNA Libraries from Corn Library Tissue Clone cc3 Corn Callus Embryo cc3.pk0007.g3 ccol Corn Cob of 67 Day Old Plants Grown in Green House ccol.pk0052.bl0 cen3n Corn Endosperm 20 Days After Pollination* cen3n.pk0062.b7 crln Corn Root From 7 Day Old Seedlings* crln.pk0154.a3 csl Corn Silk csl.pk0071.e3 etal Corn Tassel ctal.pk0005.cl *These libraries were normalized essentially as described in U.S. Pat. No. 5,482,845, incorporated herein by reference. cDNA libraries were prepared in Uni-ZAP™ XR vectors according to the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, CA). Conversion ofthe Uni-ZAP™ XR libraries into plasmid libraries was accomplished according to the protocol provided by Stratagene. Upon conversion, cDNA inserts were contained in the plasmid vector pBluescript. cDNA inserts from randomly picked bacterial colonies containing recombinant pBluescript plasmids were amplified via polymerase chain reaction using primers specific for vector sequences flanking the inserted cDNA sequences or plasmid DNA was prepared from cultured bacterial cells. Amplified insert DNAs or plasmid DNAs were sequenced in dye-primer sequencing reactions to generate partial cDNA sequences (expressed sequence tags or "ESTs"; see Adams, M. D. et al., (1991) Science 252:1651). The resulting ESTs were analyzed using a Perkin Elmer Model 377 fluorescent sequencer. EXAMPLE 2 Identification of cDNA Clones ESTs encoding SCLB R proteins were identified by conducting BLAST (Basic Local Alignment Search Tool; Altschul, S. F., et al., (1993) J. Mol. Biol 275:403-410; see also www.ncbi.nlm.nih.gov/BLAST/) searches for similarity to sequences contained in the BLAST "nr" database (comprising all non-redundant GenBank CDS translations, sequences derived from the 3-dimensional structure Brookhaven Protein Data Bank, the last major release ofthe SWISS-PROT protein sequence database, EMBL, and DDBJ databases). The cDNA sequences obtained in Example 1 were analyzed for similarity to all publicly available DNA sequences contained in the "nr" database using the BLASTN algorithm provided by the National Center for Biotechnology Information (NCBI). The DNA sequences were translated in all reading frames and compared for similarity to all publicly available protein sequences contained in the "nr" database using the BLASTX algorithm (Gish, W. and States, D. J. (1993) Nature Genetics 3:266-272) provided by the NCBI. For convenience, the P-value (probability) of observing a match of a cDNA sequence to a sequence contained in the searched databases merely by chance as calculated by BLAST are reported herein as "pLog" values, which represent the negative ofthe logarithm ofthe reported P-value. Accordingly, the greater the pLog value, the greater the likelihood that the cDNA sequence and the BLAST "hit" represent homologous proteins. EXAMPLE 3 Characterization of cDNA Clones Encoding SCLB R Proteins The BLASTX search using the nucleotide sequences from clones cen3n.pk0062.b7, csl.pk0071.e3, cc3.pk0007.g3 and ctal.pk0005.cl revealed similarity ofthe proteins encoded by the cDNAs to the barley Mlo gene (NCBI gi Accession No. 1877221). The BLASTX results for each of these ESTs are shown in Table 3: TABLE 3 BLASTX Results for Clones Encoding Polypeptides Homologous to Barley Mlo Protein BLAST pLog Score Clone 1877221 (barley) cen3n.pk0062.b7 73.04 csl.pk0071.e3 9.30 cc3.pk0007.g3 15.77 ctal.pk0005.cl 53.89 Further BLASTX analyses were performed which revealed that these ESTs and sequences from other clones contained similarities to putative Arabidopsis thaliana Mlo homologs found in the NCBI database. BLASTX search using the nucleotide sequences from clones cc3.pk0007.g3, crln.pk0154.a3 and csl.pk0071.e3 revealed similarity to the Arabidopsis thaliana AtMlo-hl protein (NCBI gi Accession No. 2765817). BLASTX search using the nucleotide sequences from clone ccol.pk0052.bl0 revealed similarity to the Barley Mlo protein isolog from Arabidopsis thaliana (NCBI gi Accession No. 2252632). The BLASTX searchs using (i) the nucleotide sequences from the contig assembled ofthe entire cDNA sequence in clone ctal.pk0005.cl and the 5' RACE product obtained using Marathon™ cDNA amplification kit (Clontech catalog No. Kl 802-1) with PCR primer P3 and (ii) using the nucleotide sequence from mlo3b3, a 3' RACE product from clone etal .pk0005.cl obtained using Marathon™ cDNA amplification kit (Clontech catalog No. Kl 802-1) with PCR primer PI, revealed similarity to the putative Mlo protein from Arabidopsis thaliana (NCBI gi Accession No. 2459447). These three Arabidopsis thaliana sequences have been identified as Mlo homologs based on sequence comparisons with the Hordeum vulgare Mlo sequence. The BLASTX search using the nucleotide sequences from the contig assembled with the sequence ofthe entire cDNA in clone cen3n.pk0062.b7 and the sequence of its 5' RACE product obtained using Marathon™ cDNA amplification kit (Clontech catalog No. Kl 802-1) with PCR primer P4 revealed a higher pLog value to the Mlo protein from Hordeum vulgare (NCBI gi Accession No. 1877221) than did the EST sequence. The BLAST results for each of these sequences are shown in Table 4: TABLE 4 BLAST Results for Clones Encoding Polypeptides Homologous to Mlo Proteins Clone NCBI gi Accession No. BLAST pLog Score cc3.pk0007.g3 2765817 > 254 crln.pk0154.a3 2765817 51.40 csl.pk0071.e3 2765817 22.70 ccol.pk0052.bl0 2252632 117.00 ctal.pk0005.cl + 2459447 177.00 5' RACE product mlo3b3 2459447 111.00 cen3n.pk0062.b7 + 1877221 168.00 5' RACE product The sequence ofthe entire cDNA insert in clone cc3.pk0007.g3 was determined and is shown in SEQ ID NO: 1; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:2. The amino acid sequence set forth in SEQ ID NO:2 was evaluated by BLASTP, yielding a pLog value >254 versus the AtMlo-hl protein sequence. The sequence of a portion ofthe cDNA insert from clone crln.pk0154.a3 is shown in SEQ ID NO:3; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:4. The sequence of a portion ofthe cDNA insert from clone csl.pk0071.e3 is shown in SEQ ID NO:5; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:6. The sequence ofthe entire cDNA insert in clone ccol .pk0052.bl0 was determined and is shown in SEQ ID NO:7; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO: 8. The amino acid sequence set forth in SEQ ID NO: 8 was evaluated by BLASTP, yielding a pLog value of 97.10 versus the barley Mlo protein isolog from Arabidopsis thaliana. The sequence ofthe contig assembled with the the entire cDNA insert in clone etal .pk0005.cl and the 5'RACE product obtained using PCR primer P3 is shown in SEQ ID NO:9; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO: 10. The amino acid sequence set forth in SEQ ID NO: 10 was evaluated by BLASTP, yielding a pLog value of 157.00 versus the putative Mlo protein from Arabidopsis thaliana. The sequence of mlo3b3, the 3' RACE product of ctal.pk0005.cl obtained using PCR primer PI, is shown in SEQ ID NO: 11 ; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO: 12. The sequence ofthe contig assembled ofthe cDNA insert from clone cen3n.pk0062.b7 and the 5' RACE product obtained using primer P4 is shown in SEQ ID NO:13; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO: 14. Comparison ofthe 3'-end sequences indicated that clones csl.pk0071.e3 and cc3.pk0007.g3 are essentially identical at their 3 '-untranslated sequences, except for a difference in the polyadenylation site (102 nt insertion), suggesting that these sequences are derived from the same gene. Clones cen3n.pk0062.b7 and ctal.pk0005.cl differ from each other and from clones csl.pk0071.e3 and cc3.pk0007.g3 in their 3 '-untranslated regions, suggesting that they may be derived from different genes. Clone mlo3b3 has a different 3 'end from its parent (etal .pk0005.cl) suggesting the presence of at least two very similar genes. The deduced protein sequences were aligned with the NCBI database sequences with the highest pLog and percent similarities were obtained. The data in Table 5 represents a calculation ofthe percent identity ofthe amino acid sequences set forth in SEQ ID NOs:2, 4, 8, 10, 12 and 14 and the Mlo (or Mlo homolog) sequences present in NCBI. TABLE 5 Percent Identity of Amino Acid Sequences Deduced From the Nucleotide Sequences of cDNA Clones Encoding Polypeptides Homologous to Mlo Proteins Clone SEQ ID NO. gi Accession No. Percent Identity cc3.pk0007.g3 2 2765817 66.4 crln.pk0154.a3 4 2765817 65.4 ccol.pk0052.bl0 8 2252632 55.4 ctal.pk0005.cl + 10 2459447 59.2 5' RACE product mlo3b3 12 2459447 60.9 cen3n.pk0062.b7 + 14 1877221 73.7 5* RACE product Sequence alignments and percent identity calculations were performed using the Megalign program ofthe LASARGENE bioinformatics computing suite (DNASTAR Inc., Madison, WI). Sequence percent identity calculations were performed by the Jotun Hein method (Hein. J. J. (1990) Meth. Enz. 753:626-645) using the default settings. For multiple alignments gap penalty=l 1, gap length penalty=3; for pairwise alignments ktuple=2. Sequence alignments and BLAST scores and probabilities indicate that the instant nucleic acid fragments encode portions, nearly entire, or entire SCLB R proteins. EXAMPLE 4 Characterization of Corn Genomic Fragments Homologous to cDNA Clone ctal .pk0005.cl A pair of PCR primers, PI and P2, were designed based on the nucleotide sequence of clone etal .pk0005.cl . PI 5'-CAGGTTCACCCACGAGACTT-3' (SEQ ID NO:15) P2 5'-TTGATGAGGAAAGAGCACGA-3' (SEQ ID NO: 16) Genomic DNA was extracted from 12 distinct corn genotypes, including CM37 and T232, and amplified via PCR using primers PI and P2 . Two amplification products were obtained from amplification of CM37 DNA, one of 765 bp in length, and the other of 703 bp in length. In contrast, amplification of T232 genomic DNA yielded a single amplification product of 703 bp in length. Nucleotide sequence analysis ofthe 765 and 703 bp PCR products (SEQ ID NOs:15 and 16, respectively) revealed a high degree of homology to the nucleotide sequence ofthe cDNA insert in clone etal .pk0005.cl . However, sequence analysis revealed that the 703 bp PCR product comprised two introns while the 765 bp product comprised three introns. The nucleotide sequence ofthe 703 bp PCR product corresponds exactly to the sequence of ctal.pk0005.cl cDNA, except for the introns (see Figure 2). Likewise, the sequence ofthe 765 bp product is 95% homologous to the etal .pk0005.cl insert sequence (again, except for the introns). Using a 3' RACE amplification system, a cDNA (mlo3b3) was obtained from etal .pk0005.cl . The nucleotide sequence of mlo3b3 is identical to the 765 bp PCR product without introns (see Figure 3). Therefore, all three amplification products are related to each other and also to the ctal.pk0005.cl cDNA insert sequence, and correspond to two corn Mlo-like genes. EXAMPLE 5 Genetic Mapping of a Corn Homolog of Barley Mlo The 765 bp PCR fragment which is produced only from amplification of CM37 genomic DNA and not from T232 genomic DNA is polymorphic between these two genotypes and can therefore be used to map its corresponding gene by analysis of PCR amplification products in a mapping population (48 individuals) resulting from a cross between CM37 and T232. Data was scored on a set of recombinant inbred lines of corn (developed by Dr. Benjamin Burr; see Burr, B. and Burr, F. A. (1991) Trends in Genetics 7:55-60 and Burr, B. et al. (1988) Genetics 775:519-526) from a cross of T232 X CM37. The results of this mapping experiment are shown in Table 6. TABLE 6 Genotype Data for a Set of Corn Chromosome 6 Markers, Including the cDNA Clone ctal.pk0005.cl Marker Genotype^ A3 BNL6.29 BBBABBBABBBBBBBAHABBAAABAABHBHBABBABBBABAAAHAABA NPI235 BBB ABBB ABBBBBBB ABABB AA AB AABHB AB ABBABBBAB A A A A A ABB BNL7.28 BBBABBBABBBBBBBABABBAAABAABBBABABBABBBABAAAAAABB ZP 15 ABB ABBB ABBBBBBB ABABBABAB A ABBB AB ABBABBBAAAA AA A ABB ctal .pk0005.cl mmBABBBAABBBBBBABABBABAAmmBBBABABBAmmBBAmAAAAABA MPIK 1 ABB ABBB ABBBBBBB ABABB ABA A A ABBB ABABB ABBBB A A A A A A ABA UMC59 ABBABBBABBBBBBBABABBABAAAABBBABABBABBBBAAAAAAAAA NPI373 AmBABBBAmBBBHBBABABHABAAAmBmBABABBABBBBAAAAmAAAA PIO200045 mBBABBBABmBmABBABABBABAAHBBBBABABAAABBBAAAAAAAAA 1 A designates CM37-like genotype. 2 B designates T232-like genotype. 3 Genotypes are listed according to the following order of recombinant inbred lines: 2, 4, 6, 7, 9, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 28, 29, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 51, 53, 54, 55, 56, 57. The data from this experiment were analyzed using the software program Mapmaker 2.0 for Macintosh (adapted from Mapmaker 2.0 for Unix; Lander et al. (1987) Genomics 7:174-181) in conjunction with segregation data obtained from Dr. Benjamin Burr for a collection of DNA markers scored in that population. The map scores from the public data set were used by Dr. B. Burr to derive map positions and genetic bin assignment, all of which are available in the Maize Genome Database (http://www.agron.missouri.edu). The data presented in Table 6 represents scoring ofthe RFLP mapping data, except in the case of etal .pk0005.cl , where the data represents the scoring of the PCR product. The RFLP or PCR pattern was examined and compared to the patterns generated from the parents ofthe genetic cross which produced the mapping population (i.e., T232 and CM37). If the pattern produced resembled that of CM37, it was designated "A". If the pattern produced resembled that of T232, it was designated "B". If the pattern produced resembled that of both CM37 and T232, it was a heterozygote and thus designated "H" . "m" denotes missing data. Mapmaker, when used as described in the instructions accompanying the software, produces a genetic map, which is shown in Figure 1. This map reveals where the Mlo cDNA clone ctal.pk0005.cl is positioned with reference to other markers. The genomic segment corresponding to the 765 bp amplification product was mapped to chromosome 6, in Bin 6.01, defined by markers BNL7.28 and UMC59. Three disease resistance loci map to the same bin on chromosome 6: maize dwarf mosaic virus (MDMV), wheat streak mosaic virus (WSMV) and southern corn leaf blight (SCLB). Ofthe three disease resistance loci, the SCLB locus is unique in that it is the only known recessive disease resistance locus in corn. Therefore, it is highly likely that the corn Mlo homolog represented by the 765 bp amplification product (containing three introns) corresponds to the southern corn leaf blight resistance gene. EXAMPLE 6 Expression of Chimeric Genes in Monocot Cells A chimeric gene comprising a cDNA encoding a SCLB R protein in sense orientation with respect to the maize 27 kD zein promoter that is located 5' to the cDNA fragment, and the 10 kD zein 3' end that is located 3' to the cDNA fragment, can be constructed. The cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) ofthe cDNA clone using appropriate oligonucleotide primers. Cloning sites (Ncol or Smal) can be incorporated into the oligonucleotides to provide proper orientation ofthe DNA fragment when inserted into the digested vector pML103 as described below. Amplification is then performed in a standard PCR. The amplified DNA is then digested with restriction enzymes Ncol and Smal and fractionated on an agarose gel. The appropriate band can be isolated from the gel and combined with a 4.9 kb Ncol-Smal fragment of the plasmid pML103. Plasmid pML103 has been deposited under the terms ofthe Budapest Treaty at ATCC (American Type Culture Collection, 10801 University Blvd., Manassas, VA 20110-2209), and bears accession number ATCC 97366. The DNA segment from pML103 contains a 1.05 kb Sail -Ncol promoter fragment ofthe maize 27 kD zein gene and a 0.96 kb Smal-Sall fragment from the 3' end ofthe maize 10 kD zein gene in the vector pGem9Zf(+) (Promega). Vector and insert DNA can be ligated at 15°C overnight, essentially as described (Maniatis). The ligated DNA may then be used to transform E. coli XL 1 -Blue (Εpicurian Coli XL-1 Blue™; Stratagene). Bacterial transformants can be screened by restriction enzyme digestion of plasmid DNA and limited nucleotide sequence analysis using the dideoxy chain termination method (Sequenase™ DNA Sequencing Kit; U. S. Biochemical). The resulting plasmid construct would comprise a chimeric gene encoding, in the 5' to 3' direction, the maize 27 kD zein promoter, a cDNA fragment encoding a SCLB R protein, and the 10 kD zein 3' region. The chimeric gene described above can then be introduced into corn cells by the following procedure. Immature corn embryos can be dissected from developing caryopses derived from crosses ofthe inbred corn lines H99 and LH132. The embryos are isolated 10 to 11 days after pollination when they are 1.0 to 1.5 mm long. The embryos are then placed with the axis-side facing down and in contact with agarose-solidified N6 medium (Chu et al., (1975) Sci. Sin. Peking 18:659-668). The embryos are kept in the dark at 27°C. Friable embryogenic callus consisting of undifferentiated masses of cells with somatic proembryoids and embryoids borne on suspensor structures proliferates from the scutellum of these immature embryos. The embryogenic callus isolated from the primary explant can be cultured on N6 medium and sub-cultured on this medium every 2 to 3 weeks. The plasmid, p35S/Ac (obtained from Dr. Peter Εckes, Hoechst Ag, Frankfurt, Germany) may be used in transformation experiments in order to provide for a selectable marker. This plasmid contains the Pat gene (see European Patent Publication 0 242 236) which encodes phosphinothricin acetyl transferase (PAT). The enzyme PAT confers resistance to herbicidal glutamine synthetase inhibitors such as phosphinothricin. The pat gene in p35S/Ac is under the control ofthe 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812) and the 3' region ofthe nopaline synthase gene from the T-DNA ofthe Ti plasmid of Agrobacterium tumefaciens. The particle bombardment method (Klein et al, (1987) Nature 327:70-73) may be used to transfer genes to the callus culture cells. According to this method, gold particles (1 μm in diameter) are coated with DNA using the following technique. Ten μg of plasmid DNAs are added to 50 μL of a suspension of gold particles (60 mg per mL). Calcium chloride (50 μL of a 2.5 M solution) and spermidine free base (20 μL of a 1.0 M solution) are added to the particles. The suspension is vortexed during the addition of these solutions. After 10 minutes, the tubes are briefly centrifuged (5 sec at 15,000 rpm) and the supernatant removed. The particles are resuspended in 200 μL of absolute ethanol, centrifuged again and the supernatant removed. The ethanol rinse is performed again and the particles resuspended in a final volume of 30 μL of ethanol. An aliquot (5 μL) ofthe DNA-coated gold particles can be placed in the center of a Kapton™ flying disc (Bio-Rad Labs). The particles are then accelerated into the corn tissue with a Biolistic™ PDS-1000/He (Bio-Rad Instruments, Hercules CA), using a helium pressure of 1000 psi, a gap distance of 0.5 cm and a flying distance of 1.0 cm. For bombardment, the embryogenic tissue is placed on filter paper over agarose- solidified N6 medium. The tissue is arranged as a thin lawn and covered a circular area of about 5 cm in diameter. The petri dish containing the tissue can be placed in the chamber of the PDS-1000/He approximately 8 cm from the stopping screen. The air in the chamber is then evacuated to a vacuum of 28 inches of Hg. The macrocarrier is accelerated with a helium shock wave using a rupture membrane that bursts when the He pressure in the shock tube reaches 1000 psi. Seven days after bombardment the tissue can be transferred to N6 medium that contains gluphosinate (2 mg per liter) and lacks casein or proline. The tissue continues to grow slowly on this medium. After an additional 2 weeks the tissue can be transferred to fresh N6 medium containing gluphosinate. After 6 weeks, areas of about 1 cm in diameter of actively growing callus can be identified on some ofthe plates containing the glufosinate- supplemented medium. These calli may continue to grow when sub-cultured on the selective medium. Plants can be regenerated from the transgenic callus by first transferring clusters of tissue to N6 medium supplemented with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be transferred to regeneration medium (Fromm et al., (1990) Bio/Technology 5:833-839). EXAMPLE 7 Expression of Chimeric Genes in Dicot Cells A seed-specific expression cassette composed ofthe promoter and transcription terminator from the gene encoding the β subunit ofthe seed storage protein phaseolin from the bean Phaseolus vulgaris (Doyle et al. (1986) J. Biol. Chem. 261 :9228-9238) can be used for expression ofthe instant SCLB R proteins in transformed soybean. The phaseolin cassette includes about 500 nucleotides upstream (5') from the translation initiation codon and about 1650 nucleotides downstream (3') from the translation stop codon of phaseolin. Between the 5' and 3' regions are the unique restriction endonuclease sites Nco I (which includes the ATG translation initiation codon), Sma I, Kpn I and Xba I. The entire cassette is flanked by Hind III sites. The cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) ofthe cDNA clone using appropriate oligonucleotide primers. Cloning sites can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the expression vector. Amplification is then performed as described above, and the isolated fragment is inserted into a pUC18 vector carrying the seed expression cassette. Soybean embroys may then be transformed with the expression vector comprising sequences encoding SCLB R proteins. To induce somatic embryos, cotyledons, 3-5 mm in length dissected from surface sterilized, immature seeds of the soybean cultivar A2872, can be cultured in the light or dark at 26°C on an appropriate agar medium for 6-10 weeks. Somatic embryos which produce secondary embryos are then excised and placed into a suitable liquid medium. After repeated selection for clusters of somatic embryos which multiplied as early, globular staged embryos, the suspensions are maintained as described below. Soybean embryogenic suspension cultures can maintained in 35 mL liquid media on a rotary shaker, 150 rpm, at 26°C with florescent lights on a 16:8 hour day /night schedule. Cultures are subcultured every two weeks by inoculating approximately 35 mg of tissue into 35 mL of liquid medium. Soybean embryogenic suspension cultures may then be transformed by the method of particle gun bombardment (Kline et al. (1987) Nature (London) 327:70, U.S. Patent No. 4,945,050). A Du Pont Biolistic™ PDS1000/HE instrument (helium retrofit) can be used for these transformations. A selectable marker gene which can be used to facilitate soybean transformation is a chimeric gene composed ofthe 35S promoter from cauliflower mosaic virus (Odell et al.(1985) Nature 373:810-812), the hygromycin phosphotransferase gene from plasmid pJR225 (from E. coli; Gritz et al.(1983) Gene 25:179-188) and the 3' region ofthe nopaline synthase gene from the T-DNA ofthe Ti plasmid of Agrobacterium tumefaciens. The seed expression cassette comprising the phaseolin 5' region, the fragment encoding the SCLB R protein and the phaseolin 3' region can be isolated as a restriction fragment. This fragment can then be inserted into a unique restriction site of the vector carrying the marker gene. To 50 μL of a 60 mg/mL 1 μm gold particle suspension is added (in order): 5 μL DNA (1 μg/μL), 20 μl spermidine (0.1 M), and 50 μL CaCl 2 (2.5 M). The particle preparation is then agitated for three minutes, spun in a microfuge for 10 seconds and the supernatant removed. The DNA-coated particles are then washed once in 400 μL 70% ethanol and resuspended in 40 μL of anhydrous ethanol. The DNA/particle suspension can be sonicated three times for one second each. Five μL ofthe DNA-coated gold particles are then loaded on each macro carrier disk. Approximately 300-400 mg of a two-week-old suspension culture is placed in an empty 60x15 mm petri dish and the residual liquid removed from the tissue with a pipette. For each transformation experiment, approximately 5-10 plates of tissue are normally bombarded. Membrane rupture pressure is set at 1100 psi and the chamber is evacuated to a vacuum of 28 inches mercury. The tissue is placed approximately 3.5 inches away from the retaining screen and bombarded three times. Following bombardment, the tissue can be divided in half and placed back into liquid and cultured as described above. Five to seven days post bombardment, the liquid media may be exchanged with fresh media, and eleven to twelve days post bombardment with fresh media containing 50 mg/mL hygromycin. This selective media can be refreshed weekly. Seven to eight weeks post bombardment, green, transformed tissue may be observed growing from untransformed, necrotic embryogenic clusters. Isolated green tissue is removed and inoculated into individual flasks to generate new, clonally propagated, transformed embryogenic suspension cultures. Each new line may be treated as an independent transformation event. These suspensions can then be subcultured and maintained as clusters of immature embryos or regenerated into whole plants by maturation and germination of individual somatic embryos. EXAMPLE 8 Expression of Chimeric Genes in Microbial Cells The cDNAs encoding the instant corn SCLB R proteins can be inserted into the T7 E. coli expression vector pBT430. This vector is a derivative of pET-3a (Rosenberg et al. (1987) Gene 56:125-135) which employs the bacteriophage T7 RNA polymerase/T7 promoter system. Plasmid pBT430 was constructed by first destroying the EcoR I and Hind III sites in pET-3a at their original positions. An oligonucleotide adaptor containing EcoR I and Hind III sites was inserted at the BamH I site of pET-3a. This created pET-3aM with additional unique cloning sites for insertion of genes into the expression vector. Then, the Nde I site at the position of translation initiation was converted to an Nco I site using oligonucleotide-directed mutagenesis. The DNA sequence of pET-3aM in this region, 5'-CATATGG, was converted to 5'-CCCATGG in pBT430. Plasmid DNA containing a cDNA may be appropriately digested to release a nucleic acid fragment encoding the protein. This fragment may then be purified on a 1% NuSieve GTG™ low melting agarose gel (FMC). Buffer and agarose contain 10 μg/ml ethidium bromide for visualization ofthe DNA fragment. The fragment can then be purified from the agarose gel by digestion with GELase™ (Epicentre Technologies) according to the manufacturer's instructions, ethanol precipitated, dried and resuspended in 20 μL of water. Appropriate oligonucleotide adapters may be ligated to the fragment using T4 DNA ligase (New England Biolabs, Beverly, MA). The fragment containing the ligated adapters can be purified from the excess adapters using low melting agarose as described above. The vector pBT430 is digested, dephosphorylated with alkaline phosphatase (NEB) and deproteinized with phenol/chloroform as described above. The prepared vector pBT430 and fragment can then be ligated at 16°C for 15 hours followed by transformation into DH5 electrocompetent cells (GIBCO BRL). Transformants can be selected on agar plates containing LB media and 100 μg/mL ampicillin. Transformants containing the gene encoding the SCLB R protein are then screened for the correct orientation with respect to the T7 promoter by restriction enzyme analysis. For high level expression, a plasmid clone with the cDNA insert in the correct orientation relative to the T7 promoter can be transformed into E. coli strain BL21(DΕ3) (Studier et al. (1986) J. Mol. Biol. 759:113-130). Cultures are grown in LB medium containing ampicillin (100 mg/L) at 25°C. At an optical density at 600 nm of approximately 1, IPTG (isopropylthio-β-galactoside, the inducer) can be added to a final concentration of 0.4 mM and incubation can be continued for 3 h at 25°. Cells are then harvested by centrifugation and re-suspended in 50 μL of 50 mM Tris-HCl at pH 8.0 containing 0.1 mM DTT and 0.2 mM phenyl mefhylsulfonyl fluoride. A small amount of 1 mm glass beads can be added and the mixture sonicated 3 times for about 5 seconds each time with a microprobe sonicator. The mixture is centrifuged and the protein concentration ofthe supernatant determined. One μg of protein from the soluble fraction ofthe culture can be separated by SDS-polyacrylamide gel electrophoresis. Gels can be observed for protein bands migrating at the expected molecular weight.

Claims: CLAIMS What is claimed is: 1. An isolated nucleic acid fragment encoding all or a substantial portion of a SCLB R protein comprising a member selected from the group consisting of: (a) an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO.10, SEQ ID NO:12 and SEQ ID NO:14; (b) an isolated nucleic acid fragment that is substantially similar to an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO.10, SEQ ID NO:12 and SEQ ID NO:14; and (c) an isolated nucleic acid fragment that is complementary to (a) or (b). 2. The isolated nucleic acid fragment of Claim 1 wherein the nucleotide sequence ofthe fragment comprises all or a portion ofthe sequence set forth in a member selected from the group consisting of SEQ ID NO:l, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:19, SEQ ID NOT 1, SEQ ID NO.13, SEQ ID NO:18 and SEQ ID NO:19. 3. A chimeric gene comprising the nucleic acid fragment of Claim 1 operably linked to suitable regulatory sequences. 4. A transformed host cell comprising the chimeric gene of Claim 3. 5. A SCLB R polypeptide comprising all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:12 and SEQ ID NO:14. 6. A method of altering the level of expression of a SCLB R protein in a host cell comprising: (a) transforming a host cell with the chimeric gene of any of Claim 3 ; and (b) growing the transformed host cell produced in step (a) under conditions that are suitable for expression ofthe chimeric gene wherein expression ofthe chimeric gene results in production of altered levels of SCLB R protein in the transformed host cell. 7. A method of obtaining a nucleic acid fragment encoding all or a substantial portion ofthe amino acid sequence encoding a SCLB R protein comprising: (a) probing a cDNA or genomic library with the nucleic acid fragment of any of Claim 1 ; (b) identifying a DNA clone that hybridizes with the nucleic acid fragment of any of Claim 1 ; (c) isolating the DNA clone identified in step (b); and (d) sequencing the cDNA or genomic fragment that comprises the clone isolated in step (c) wherein the sequenced nucleic acid fragment encodes all or a substantial portion ofthe amino acid sequence encoding a SCLB R protein. 8. A method of obtaining a nucleic acid fragment encoding a substantial portion of an amino acid sequence encoding a SCLB R protein comprising: (a) synthesizing an oligonucleotide primer corresponding to a portion ofthe sequence set forth in any of SEQ ID NOs.l, 3, 5, 7, 9, 11, 13, 18 and 19; and (b) amplifying a cDNA insert present in a cloning vector using the oligonucleotide primer of step (a) and a primer representing sequences ofthe cloning vector wherein the amplified nucleic acid fragment encodes a substantial portion of an amino acid sequence encoding a SCLB R protein. 9. The product ofthe method of Claim 7. 10. The product of the method of Claim 8.

Inventors: CAHOON REBECCA E, MIAO GUO-HUA, RAFALSKI J ANTONI, TARAMINO GRAZIANA, CAHOON, REBECCA, E., MIAO, GUO-HUA, RAFALSKI, J., ANTONI, TARAMINO, GRAZIANA
Applicants: CAHOON REBECCA E, DU PONT, MIAO GUO HUA, RAFALSKI J ANTONI, TARAMINO GRAZIANA, CAHOON, REBECCA, E., E.I. DU PONT DE NEMOURS AND COMPANY, MIAO, GUO-HUA, RAFALSKI, J., ANTONI, TARAMINO, GRAZIANA
Application year: 1998
Main classification: C12N15
IPC codes: C07K14, C12N15